A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample

Drug and Alcohol Review
Simon J Adamson, J Douglas Sellman

Abstract

The Cannabis Use Disorders Identification Test (CUDIT) was used for the first time as part of a randomized controlled trial for brief interventions in mild to moderate alcohol-dependent out-patients. This sample may be seen as a population at increased risk of cannabis use disorder. The CUDIT was developed by modifying the Alcohol Use Disorders Identification Test (AUDIT). The ability of the CUDIT to accurately screen for cannabis abuse or dependence was examined in the portion of the sample who reported some cannabis use over the preceding 6 months (n=53), as was self-reported frequency of cannabis use in the preceding 6 months. The CUDIT was superior to the frequency measure, achieving positive predictive power of 84.6% and sensitivity of 73.3% at a cut-off of 8, compared to positive predictive power of 81.8% and sensitivity of 60.0% for 80 or more cannabis use-days. These results indicate the viability of a screening measure for identifying cannabis use disorder in at risk populations.

Citations

Jan 24, 2012·Addiction Biology·Janna CousijnReinout W Wiers
Mar 13, 2014·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Yves HenchozGerhard Gmel
Feb 19, 2016·Journal of Applied Toxicology : JAT·Rebecca L HartmanMarilyn A Huestis
Feb 10, 2016·Biological Psychiatry·Valentina LorenzettiMurat Yücel
Apr 30, 2015·Developmental Cognitive Neuroscience·Janna CousijnRenske Spijkerman
Sep 27, 2014·Behavioral Medicine·Yves HenchozGerhard Gmel
Oct 15, 2013·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Stéphanie BaggioGerhard Gmel
Sep 28, 2010·Drug and Alcohol Dependence·Stéphane LegleyeLudwig Kraus
Sep 3, 2010·International Journal of Methods in Psychiatric Research·Beatrice AnnaheimGerhard Gmel
Oct 18, 2011·The American Journal on Addictions·Eric GuillemJean-Pierre Lépine
Jul 28, 2006·Addictive Behaviors·Katarzyna Okulicz-Kozaryn, Janusz Sierosławski
Jul 17, 2015·Drug and Alcohol Review·Louise K ThorntonFrances J Kay-Lambkin
Feb 14, 2015·Drug and Alcohol Review·Julia BeckerMichael P Schaub
Jul 7, 2015·Drug and Alcohol Dependence·Rebecca L HartmanMarilyn A Huestis
Jan 24, 2013·Drug and Alcohol Dependence·Danielle E RamoJudith J Prochaska
Dec 6, 2008·Substance Abuse Treatment, Prevention, and Policy·Daniela PiontekDanica Klempova
Apr 22, 2014·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Emeline ChauchardDavid A Gorelick
Aug 25, 2016·Substance Use & Misuse·Cristina CasajuanaAntoni Gual
Sep 7, 2016·Revue D'épidémiologie Et De Santé Publique·S BaggioG Gmel
Sep 4, 2016·Drug and Alcohol Dependence·Randi Melissa SchusterA Eden Evins
Jul 26, 2017·Journal of Psychopharmacology·L KoendersJ Cousijn
Oct 24, 2017·The American Journal of Drug and Alcohol Abuse·Mallory LoflinMarcel Bonn-Miller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.